85. Idiopathic interstitial pneumonia
514 clinical trials,   377 drugs   (DrugBank: 108 drugs),   97 drug target genes,   204 drug target pathways

Searched query = "Idiopathic interstitial pneumonia", "IIPs", "Idiopathic pulmonary fibrosis", "IPF", "Usual interstitial pneumonia", "UIP", "Non-specific interstitial pneumonia", "NSIP", "Acute interstitial pneumonia", "AIP", "Diffuse alveolar damage", "DAD", "COP", "Organizing pneumonia", "OP", "Desquamative interstitial pneumonia", "DIP", "Respiratory bronchiolitis - associated interstitial lung disease", "RB-ILD", "Lymphocytic interstitial pneumonia", "LIP"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2010-023828-24-GB
(EUCTR)
09/06/201127/04/2011The effect of Thalidomide on sputum biomarkers in IPF cough. - The effect of Thalidomide on sputum biomarkers in IPF coughThe effect of Thalidomide on sputum biomarkers in IPF cough. - The effect of Thalidomide on sputum biomarkers in IPF cough Cough in Idiopathic Pulmonary fibrosis.Trade Name: Thalidomide Pharmion
Product Name: Thalidomide Pharmion
Trade Name: PREDNISOLONE
Product Name: prednisolone
University of NottinghamNULLNot RecruitingFemale: yes
Male: yes
United Kingdom
2NCT00600028
(ClinicalTrials.gov)
December 200711/1/2008Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With ThalidomideTreatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With ThalidomideIdiopathic Pulmonary Fibrosis;CoughDrug: Thalidomide;Drug: PlaceboJohns Hopkins UniversityNULLCompleted50 YearsN/AAll25Phase 3United States
3NCT00162760
(ClinicalTrials.gov)
October 20038/9/2005Treatment of Idiopathic Pulmonary Fibrosis With ThalidomideTreatment of Idiopathic Pulmonary Fibrosis With ThalidomideIdiopathic Pulmonary Fibrosis (IPF)Drug: ThalidomideJohns Hopkins UniversityCelgene CorporationCompleted50 Years80 YearsBoth19Phase 2United States